| ACIT | Adoptive Chemoimmunotherapy |
|---|---|
| AIT | Adoptive immunotherapy |
| adoptive immunity | <immunology> Immunity to disease or infection conferred on a previously non-immune individual by transferring lymphocytes from a previously immune individual to the non-immune individual. (15 Jan 1998) |
|---|---|
| adoptive transfer | Form of passive immunization where previously sensitised immunologic agents (cells or serum) are transferred to non-immune recipients. When transfer of cells is used as a therapy for the treatment of neoplasms, it is called adoptive immunotherapy (immunotherapy, adoptive). (12 Dec 1998) |
| immunotherapy, adoptive | Form of adoptive transfer where cells with antitumour activity are transferred to the tumour-bearing host in order to mediate tumour regression. The lymphoid cells commonly used are lymphokine-activated killer (lak) cells and tumour-infiltrating lymphocytes (til). This is usually considered a form of passive immunotherapy. (12 Dec 1998) |
| adoptive i. |
passive immunity of the cell-mediated type conferred by the administration of sensitized lymphocytes from an immune donor.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|